



































































































































































1 2 PCI FFR 0.75
DEFER study6 FFR 0.75 PCI 5
1 PCI
FFR 0.75 PCI 34











































LCX FFR 0.69 LMT
7 LMT Promus 3.5/16 mm
3.0 & 2.5 mm KBT
8 FFR LAD FFR











Bare Metal Stent BMS diffuse lesion one point





5 Bruyne 12 LMT PCI
FFR 0.80 LMT refer-
ence vessel size
FFR 0.80




6 FAME study Angio-guided PCI FFR-guided PCI
13 1
18.3 vs 13.2
2.7 1.9 Angio-guide 50 PCI
FAME substudy Angio-guide 3 VD
MPI FFR Functional 3 VD 14 Angio-guide 2 3
MVD Functional MVD 46 14
Syntax Score FFR Score
10























































































FFR MACE TVR 18
0.90 PCI Cut-off 0.80
DES
FFR 0.80
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Abstruct
The myocardial fractional flow reserve (FFRmyo) can be interpreted as the maximal flow to
the target vessel in the presence of stenosis as a percentage of the maximal flow in the hypo-
thetical absence of stenosis. The FFRmyo is different from the index derived from the cross-
sectional area obtained by IVUS and coronary angiography in that the inducement of ischemia
can be assessed with a single index irrespective of the site of stenosis, including periphery
branches and the left main trunk. The normal FFRmyo is theoretically equal to 1.0 ; the thresh-
old of ischemia induction is 0.75 ; and studies showed that ischemia is not inducible if the
FFRmyo is more than 0.80. Although the presence of ischemia in the perfusion area can be as-
sessed with the FFRmyo, a major weak point of this index comparing to nuclear medicine is its
inability to determine the ischemic volume of the myocardium, which is important for the prog-
nosis. The DEFER study evaluated the FFRmyo to determine the appropriateness of angioplasty,
and the FAME study examined patients with multivessel disease. Both studies showed that the
indication of angioplasty should be based on the functional severity of stenosis indicated by the
FFRmyo, and not based on findings of coronary angiography, and that the significant improve-
ment of outcomes cannot be expected for patients without ischemia. Furthermore the FAME II
study showed that, for patients whose FFRmyo is less than 0.80, the risk of urgent angioplasty
was lower in patients who received FFR-guided PCI in addition to optimal medical treatment
(OMT) than those treated with OMT alone.
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